Purpose To investigate if the timing of initiation of invasive mechanical ventilation (IMV) for critically ill patients with COVID-19 is associated with mortality. Materials and methods The data for this study were derived from a multicenter cohort study of critically ill adults with COVID-19 admitted to ICUs at 68 hospitals across the US from March 1 to July 1, 2020. We examined the association between early (ICU days 1–2) versus late (ICU days 3–7) initiation of IMV and time-to-death. Patients were followed until the first of hospital discharge, death, or 90 days. We adjusted for confounding using a multivariable Cox model. Results Among the 1879 patients included in this analysis (1199 male [63.8%]; median age, 63 [IQR, 53–72] years), 1526 (81.2%) initiated IMV early and 353 (18.8%) initiated IMV late. A total of 644 of the 1526 patients (42.2%) in the early IMV group died, and 180 of the 353 (51.0%) in the late IMV group died (adjusted HR 0.77 [95% CI, 0.65–0.93]). Conclusions In critically ill adults with respiratory failure from COVID-19, early compared to late initiation of IMV is associated with reduced mortality.
Objective : Continuous renal replacement therapy (CRRT) in patients receiving venovenous extracorporeal membrane oxygenation (VV ECMO) can be accessed via separate venous access (SVA) or directly “in-line” within the ECMO circuit. The objective of this study is to compare the efficacy and safety of SVA versus in-line configuration in patients requiring CRRT and VV ECMO. Design: A retrospective review of 16 subjects receiving CRRT while on VV ECMO support. Setting: Adult ICU at a tertiary academic medical institution. Patients: Critically ill adult subjects with severe respiratory failure undergoing percutaneous VV ECMO and CRRT. Interventions: CRRT with venous access via separate temporary hemodialysis catheter versus direct access in-line with the VV ECMO circuit. Measurements and Results: Subject demographics, ECMO cannulation configuration, duration of CRRT, oxygenator and CRRT filter lifespan, number of interruptions, and dialysis blood flow rate were recorded. Five patients received CRRT via SVA and 11 patients via in-line configuration. There was a higher mean number of days on CRRT in the in-line group (7 vs 12 days, p = 0.32). There was no significant difference in oxygenator lifespan (days) (17.1 vs 14.72, p = 0.597), CRRT filter lifespan (days) (1.68 vs 2.15 p = 0.136), or interruptions per 100 CRRT days (10 vs 11.73, p = 0.834) in SVA vs in-line groups. Percentage days with therapeutic anticoagulation (65 vs 68, p =0.859) and initial dialysis blood flow rate (300 vs 310.91 mL/min, p = 0.258) were similar between configurations. SVA was associated with frequent access site manipulation (60% of patients) and catheter site bleeding (40% of patients). Conclusions: CRRT can be delivered via SVA or in-line configuration in patients requiring VV ECMO with similar efficacy. Separate venous access for CRRT may be associated with higher rates of access associated bleeding and need for access manipulation when compared to in-line configuration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.